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Abstract 
Stephen M. Albert, PhD, MS 
 
Evaluation of a Medication Management Program for Older Adults 
 
Lindsay F. Bell, MPH 
 
University of Pittsburgh, 2020 
 
Abstract 
 
Background: As the prevalence of chronic disease increases among older adults in the United 
States, the need for medical interventions to adequately manage disease is also growing. Increased 
prescription drug use and care by multiple health providers among older adults are associated with 
potentially inappropriate prescribing, which may lead to adverse drug events. The HomeMeds 
Medication Assurance Program (HomeMeds program) is an in-home medication risk assessment 
for older adults to identify and prevent potentially inappropriate prescribing.  
Objective: To determine the effectiveness of the HomeMeds program by describing the attitudes 
about the program among the target population, identifying barriers and facilitators to the program, 
and evaluating the results of medication risk assessments. 
Methods: Qualitative data were collected through focus group sessions with members of the target 
population and key informant interviews with HomeMeds program staff and experts in geriatric 
clinical pharmacy. Quantitative data were collected using the HomeMeds program database. 
Results: Barriers to participation in the program were a lack of awareness about the susceptibility 
and severity of potentially inappropriate prescribing among older adults, trust in the health care 
system to accurately track medications, and fear of breach in confidentiality. Clients who took five 
or more medications were more likely to have an alert generated in the HomeMeds system than 
clients who took fewer medications. Despite this, less than 35% of alerts resulted in follow-up 
consultations between the partnering pharmacist and client. HomeMeds staff experienced 
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challenges with recruiting individuals and providing clinically relevant recommendations about 
medications. 
Conclusion: The public health significance of this study is that community programs that 
implement medication risk assessments may not be effective in preventing potentially 
inappropriate prescribing in older adults. Improvements to the HomeMeds program should include 
pharmacist-led educational sessions to provide the information necessary to motivate participation 
in the program. Program champions at AgeWell residential sites should be leveraged to identify 
vulnerable older adults and facilitate participation. Finally, partnerships with local primary care 
practices should be formed to recruit clients to the program, provide comprehensive information 
about clients’ health history, and evaluate outcomes that result from participation.   
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1.0 Introduction 
The HomeMeds Medication Assurance Program is an evidence-based program to prevent 
potentially inappropriate prescribing in older adults. Issues related to potentially inappropriate 
prescribing, which may lead to medication errors, are often associated with aging. To combat this, 
the HomeMeds program provides an in-home review of clients’ prescription and non-prescription 
drugs. Medications are entered into the HomeMeds database and assessed by a pharmacist. Follow-
up consultations between the client and pharmacist are conducted to ensure appropriate medication 
management. If therapeutic duplications or harmful drug interactions are indicated, the pharmacist 
will provide recommendations for remediation. Pharmacists may also contact the client’s 
prescriber with their findings. The main purpose of the HomeMeds program is to identify and alert 
older adults and their healthcare providers to possible risks associated with their medications 
through a systematic, comprehensive review of their prescription and non-prescription drugs. 
AgeWell Pittsburgh began the HomeMeds Medication Assurance Program in 2015. 
AgeWell Pittsburgh is an organization that provides resources for older adults and their caregivers 
to help them address issues associated with aging. AgeWell is a collaboration between three local 
agencies within Pittsburgh, PA: the Jewish Community Center of Greater Pittsburgh, the Jewish 
Family & Community Services, and the Jewish Association on Aging. Operating through each of 
these agencies, AgeWell supports over 10,000 clients and caregivers. Outreach occurs throughout 
the greater Pittsburgh area in community centers, low-income housing units, and senior living 
facilities. AgeWell Pittsburgh is sustained through funding provided by the United Way of 
Southwestern Pennsylvania, the Jewish Healthcare Foundation, the Allegheny County Department 
of Human Services, and the Jewish Federation of Greater Pittsburgh.  The mission of AgeWell is 
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to implement community-based programs that allow seniors to live independently in their home. 
AgeWell services include transportation, food and nutrition programs, caregiver resources, 
bereavement support groups, counseling, and care coordination. Included in the services provided 
by AgeWell Pittsburgh is the HomeMeds program, a medication management program for older 
adults.  
Given the large population of older adults in Southwestern Pennsylvania and clients who 
use AgeWell services, this program is a vital tool for driving the AgeWell mission to keep older 
adults safely at home. However, the program has consistently experienced challenges with 
recruiting participants. Because the program does not implement regular evaluation, further 
research is needed to determine the feasibility and acceptability of the program and inform future 
operations of HomeMeds. In this study, I will use mixed methods to analyze the effectiveness of 
the HomeMeds program and provide recommendations to help address barriers and broaden the 
reach of its services. My specific aims are:   
Specific Aim 1: To evaluate the prevalence of risks associated with polypharmacy among 
participants in the HomeMeds program.   
Hypothesis 1: HomeMeds program clients who are prescribed five or more medications are more 
likely to have a medication alert generated by the HomeMeds database than clients who 
take fewer medications. 
Specific Aim 2: To describe the attitudes and perspectives about the HomeMeds program among 
the target population and HomeMeds staff.   
Hypothesis 2: Members of the target population are reluctant to participate in the program due to 
a lack of trust in the HomeMeds staff and minimal knowledge about potentially inappropriate 
prescribing in the health care system. 
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2.0 Background 
2.1 Aging, Chronic Disease, and Health Care Utilization  
In 1900, life expectancy in the United States was 47.3 years of age[1]. The most common 
cause of death was infectious disease [2]. Today, despite a recent decline from the effects of opioid-
related deaths and the emerging impact of the coronavirus pandemic, life expectancy is now 78.7 
years[3]. Accompanied by a decreasing birth rate, the country faces an aging population[2]. By 
2030, over 20% of the United States population will be adults over the age of 65 years[4, 5]. 
Because health care has shifted and the ability to manage infectious disease has improved, chronic 
disease has emerged as the leading cause of death in the United States[3, 6]. A chronic disease is 
an ongoing, usually incurable illness that requires continuing medical intervention and may 
interfere with activities of daily living[6, 7]. Over 50% of the U.S. population suffers from a 
chronic disease[6, 8]. This is especially common among older adults, 80% of whom suffer from at 
least one chronic condition[9]. For instance, more than 22% of adults over the age of 65 suffer 
from diabetes and almost 60% of Medicare beneficiaries over the age of 65 have been diagnosed 
with hypertension[10]. Moreover, older adults are also more likely to suffer from multiple 
comorbidities. Approximately 77% of older adults suffer from two or more chronic diseases[9].  
The strain of managing multiple chronic conditions creates both personal and health 
system-wide challenges[6]. As the prevalence of chronic disease increases in the United States, 
the need for medical interventions to adequately manage disease is also growing. Approximately 
75% of annual health care expenditures in the U.S. are used to treat chronic diseases[9]. Given the 
state of the nation’s aging population and the corresponding increase in chronic disease, this 
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burden on the health care system is likely to intensify[6]. Overall, patients with multiple chronic 
diseases require more health care services, such as emergency department stays, inpatient and 
outpatient visits, and prescription drugs[8]. This results in increased health care expenditures, 
where individuals with five or more chronic diseases spend 14 times more on health care services 
than individuals with no chronic conditions. On average, these individuals also use twice as many 
drugs each year than individuals with only three or four chronic diseases[8]. Not surprisingly, 
increasing reliance on prescription drugs to manage disease has had an impact on the population 
of older adults with chronic conditions. Subsequently, as the prevalence of chronic disease in 
individuals over the age of 65 increases, polypharmacy, or the simultaneous use of five or more 
medications, has become more prevalent among older adults[11, 12]. In 2010, nearly 40% of adults 
over the age of 65 were taking five or more medications[13]. While the use of prescription drugs 
is a vital aspect of health maintenance, polypharmacy can also lead to unintended, negative health 
outcomes. 
2.2 Polypharmacy and Adverse Drug Events 
Among the complications associated with polypharmacy is an increased risk of drug 
duplication, harmful drug interactions, and medication errors that lead to adverse drug events[14-
17]. An adverse drug event is an unintended, harmful event caused by a drug. This may manifest 
in any of the body’s systems, including the central nervous system, gastrointestinal system, and 
dermatologic system[18]. The outcomes of an adverse drug event can range from undetected to 
fatal. For example, common signs and symptoms associated with an adverse drug event include 
dizziness, cognitive impairment, or unintentional overdose[16, 18, 19]. Evidence suggests that the 
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risk for adverse drug events increases significantly with the number of drugs consumed[18, 20]. 
Along with the harmful health outcomes that may result from an adverse drug event, it is also 
associated with increased health care utilization. Adverse drug events account for almost 300,000 
hospital admissions each year and are estimated to result in over $5 million in health care costs[12]. 
In addition to the risks that older adults are exposed to through polypharmacy, aging-related 
physiologic changes, such as altered metabolism, decline in renal function, and decreased body 
mass, may make them more susceptible to adverse drug events[16, 21].  Subsequently, adverse 
drug events are a leading cause of emergency department visits by older adults[22].   
Another consequence of adverse drug events that can be caused by polypharmacy are 
increased frequency of falls[23-25]. The World Health Organization defines a fall as “an event 
which results in a person coming to rest inadvertently on the ground or floor or other lower 
level”[26]. Although physiologic changes that accompany aging may explain the incidence of falls 
in older adults, the cumulative effects of chronic disease and the drugs needed to treat them also 
contribute to this risk[27]. Approximately one in three people over the age of 65 fall each year[28]. 
Falls account for the leading cause of fatal and nonfatal injuries, such as fractures and traumatic 
brain injuries, in older adults[9, 27]. They are also the seventh most common cause of death in 
people over the age of 65 [9, 28, 29]. In addition, injuries related to falls may result in multiple 
complications that interfere with an individual’s capacity to perform activities of daily living. 
Similar to other outcomes associated with adverse drug events, falls result in increased health care 
utilization. Hence, approximately $50 billion are spent on the treatment of fatal and non-fatal falls 
in the United States each year[27].  
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2.3 Factors Contributing to Polypharmacy and Medication Errors 
There are many factors that contribute to polypharmacy and medication errors in the U.S. 
One of the most common factors is the challenge of navigating a complex healthcare system with 
chronic disease. As an individual’s comorbidities increase, they also experience a greater need for 
care by multiple medical providers. Evidence suggests that the number of healthcare providers 
treating a patient is an independent risk factor for adverse drug events[30, 31]. This may be caused 
by polypharmacy or medication errors that result from potentially inappropriate prescribing. An 
estimated 50% of adverse drug events are caused by errors when prescribing or dispensing a 
drug[18]. Potentially inappropriate prescribing increases after a hospital admission and often 
occurs during transitions of care[21, 32]. Possible explanations for potentially inappropriate 
prescribing are a lack of communication between multiple healthcare providers and failure to 
correct resulting medication errors. Additionally, the cascade effect, or use of a medication to treat 
a side effect caused by a different medication, may further exacerbate this situation[33]. 
Consequently, individuals who require multiple medical interventions are also at an increased risk 
for potentially inappropriate prescribing. Given that older adults have more comorbidities, may be 
treated by multiple providers, and require complex drug regimens, they are therefore more likely 
to experience adverse drug events that are caused by potentially inappropriate prescribing[12, 15].  
In addition to factors in the health care system, another issue that may contribute to adverse 
drug events are inappropriate drug administration. Approximately 30% of adverse drug events are 
caused by incorrect administration of a medication[18]. This error could occur with any variable 
in the administration process (e.g. type of medication administered, dose, time, etc.).  While human 
error will always be a factor in inappropriate medication administration, low health literacy is also 
likely to magnify this issue. The Office of Disease Prevention and Health Promotion defines health 
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literacy as “the ability to obtain, process, and understand basic health information and services to 
make appropriate health decisions[34].” Only 21% of adults in the United States have a basic 
health literacy level and 14% have a below basic health literacy level[34]. Evidence suggests that 
low health literacy is attributed to low medication adherence and increased hospital readmission 
rates[35-38]. For older adults who have complex drug regimens, health literacy can be a crucial 
factor in their ability to appropriately manage their medications. For example, in a longitudinal 
study of older adults with complicated drug routines, individuals with low health literacy were 
more likely to make a medication error[38]. It is estimated that only 3% of adults over the age of 
65 have a proficient health literacy[39]. As a result, health literacy in older adults may be a factor 
contributing to the complications with medication management and prevalence of adverse drug 
events in this population.  
2.4 Needs Assessment for Older Adults in Pittsburgh 
Approximately 18.9% of Allegheny County’s population is over the age of 65, more than 
3% above the current national average[40]. With a growing older population, the county faces an 
important challenge to assist and care for individuals who may have multiple comorbidities, higher 
health care burdens, and a declining ability to maintain their basic needs. Moreover, data suggest 
that the population of older adults in Allegheny County experience the same risks associated with 
aging that are seen in national trends. In 2018, over 5,000 Allegheny County residents above the 
age of 65 were hospitalized from a fall. This age-group accounted for more than 73% of all fall-
related hospitalizations[41]. In the same year, falls were also the most common mechanism for an 
injury-related hospitalization and cost over $550 million in total medical costs. Additionally, 10% 
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of Allegheny County residents are functionally illiterate [42]. There is no data regarding the health 
literacy of Allegheny County residents. However, following national projections of health literacy 
for people over the age of 65, this could be a significant problem for older adults in Allegheny 
County and create barriers to proper medication management. Considering these factors, it is likely 
that older adults in Allegheny County also experience the risks associated with potentially 
inappropriate prescribing and adverse drug events. Given the rate at which Allegheny County’s 
population is aging, the services provided by the HomeMeds Medication Assurance Program could 
help at-risk older adults maintain their independence and remain living safely at home. 
Furthermore, the HomeMeds program could help to address the personal and system-wide burdens 
associated with potentially inappropriate prescribing by decreasing adverse drug events and health 
care expenditures for older adults in Allegheny County.  
2.5 Partners in Care HomeMeds Program 
HomeMeds is an evidence-based program developed by the Partners in Care Foundation 
to review clients’ medications and identify potentially inappropriate prescribing that could lead to 
adverse drug events. The intervention aims to address potentially inappropriate prescribing 
commonly caused by lapses in communication and care coordination between clinicians[32]. 
Given that older adults represent nearly 40% of patients affected by medication errors, the program 
focuses on individuals who are over the age of 65[43]. Approximately 48% of community-
dwelling older adults take potentially inappropriate medications (i.e. drugs identified as 
inappropriate in all circumstances regardless of disease or dosage)[44]. Subsequently, the 
HomeMeds program also focuses specifically on older adults who are community-dwelling. 
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Similar to AgeWell Pittsburgh, the Partners in Care Foundation uses community-based care 
services to improve the health and self-efficacy of individuals with chronic disease. As a result, 
the HomeMeds program was developed to reduce hospitalizations and readmissions, monitor drug 
adherence, and prevent medication-related adverse events in community-dwelling older adults. 
The overarching goal of this program is to identify and alert individuals and their clinicians about 
the potential risks associated with a client’s medications that may cause an adverse drug event. 
The HomeMeds intervention (see Figure 1) is based on existing literature that pharmacists 
play a key role in the medication management of older adults[32, 45, 46]. However, a pharmacist 
is often an underutilized resource in the care of patients with multiple comorbidities who receive 
treatment from numerous medical providers[47]. Research has found that similar interventions, 
which implement a pharmacist-led review of patients’ prescription and non-prescription drugs, 
helped to improve care coordination for older adults and systematically monitor their 
medications[46-52]. Medication management interventions have led to increased patient self-
advocacy, independence, and medication adherence[49, 51]. Additionally, program outcomes 
Figure 1. HomeMeds Intervention Process 
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often included a reduction in the client’s dosage and monthly prescription drug costs[47, 50, 51]. 
Thus, through this program, the Partners in Care Foundation aims to promote patient self-efficacy, 
independence, and safety.  
Developed in 2011, the HomeMeds Medication Safety Program uses an online software 
database to implement a computerized medication risk assessment screening and alert process for 
possible adverse drug events. The HomeMeds program is a joint operation between community-
based organizations that coordinate the review of the client’s medications and contracted 
pharmacists who interpret the medication risk assessment results. Since its inception, the program 
has served over 10,000 older adults, nearly 50% of whom had a risk associated with their 
medications[14].  HomeMeds has been implemented in 18 states in the U.S. and is an approved 
Disease Prevention and Health Promotion program[14]. It has received a strong evidence rating 
on the U.S. Agency for Healthcare Research and Quality Innovation Exchange and was awarded 
the Highest Evidence Level rating by the U.S. Administration for Community Living. The Partners 
in Care Foundation also operates a more recently developed HomeMeds Plus Program. This is a 
three-step intervention to reduce emergency department and hospital readmissions for at-risk older 
adults. Along with a medication risk assessment HomeMeds Plus features a psychosocial and 
environmental risk assessment and the development of an individualized service plan for clients. 
Service plans include the creation of a risk assessment follow-up strategy, based on the client’s 
needs, with family caregivers or care coordinators[14]. 
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2.6 AgeWell Pittsburgh HomeMeds Program 
Similar to the Partners in Care Foundation, AgeWell Pittsburgh serves as the community-
based organization that funds and implements the HomeMeds program. Given the three-pronged 
approach to the provision of AgeWell services, the HomeMeds staff who coordinate the program 
are either a senior center staff person (Jewish Community Center), nurse navigator (Jewish 
Association on Aging), or social worker (Jewish Family & Community Services). The medication 
review can take place in the client’s home or at the coordinating agency. This intervention begins 
with informed consent provided by the client. Then, the HomeMeds staff member records the basic 
demographic information and self-reported medical history of the client. Depending on the 
location of the visit, medication information is collected using a medication information form or 
entered directly into the online HomeMeds database. During each visit, the client’s blood pressure 
and pulse are recorded using a digital wrist blood pressure monitor. Each of these categories of 
data (see Table 1.) are added to the client’s profile in the HomeMeds database. 
Table 1. HomeMeds Program: Collected and Recorded Medication Information 
Variable Example 
Name of Medication  Brand or generic name 
Dosage or Strength 10mg 
Amount/form 1 tablet; ½ teaspoon 
Frequency Every 4 hours, or 3 per day 
Route Oral 
Prescribing Physician  Name & Phone Number 
Dispensing Pharmacy Name & Phone Number 
 
Giant Eagle Pharmacy is contracted by AgeWell Pittsburgh to provide the clinical expertise 
needed for the interpretation of the online medication risk assessment results. Each week, the Giant 
Eagle pharmacy team is sent a report with new clients’ medication assessments. Reports include 
each client’s basic information (i.e. name, date of assessment, and assessment site). The pharmacy 
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team will then review all new clients in the HomeMeds database. If no alert is generated in the 
database, they will mail a report documenting this information to the client. If an alert is generated, 
the pharmacist will review the alert to determine if it is clinically-significant. If the pharmacist 
determines that the alert is legitimate, they will call and consult with the client to provide education 
and recommendations. The client may provide permission for the pharmacist to contact their 
prescribing physician with their results and recommendations. Barring medical emergencies, 
contact by the pharmacist to the prescribing physician is only made if permission is given by the 
client. If a client cannot be reached by telephone, the pharmacist will send a letter to the client’s 
home requesting that they call the pharmacy for the results of their medication risk assessment.  
Once the pharmacist has spoken with the client over the phone, they will send a final report with 
their findings to their home. The AgeWell HomeMeds program does not include documentation 
of whether medication changes were made by the prescribing physician. Additionally, clients are 
not followed after participating in the program to track possible adverse drug events, overall health 
care utilization, or other outcomes that result from the medication risk assessment. 
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3.0 Methods 
3.1 Qualitative Data Collection and Analysis 
Qualitative data in this study were collected through focus group sessions and key 
informant interviews conducted in December 2019 and January 2020.  Focus group sessions were 
held with members of the HomeMeds program target population—individuals who are 65 years 
and older and live in the greater-Pittsburgh area. The focus group sessions were conducted at the 
Jewish Community Center and New Riverview Apartments, which are sites associated with 
AgeWell Pittsburgh. The sessions were conducted with two key groups of the target population: 
members of the Jewish Community Center who have previously participated in the program and 
residents of the New Riverview Apartments who have not participated in the HomeMeds program. 
Previous participants were chosen to provide their perspectives on the benefits of participation, 
experience with using the program, and knowledge about potentially inappropriate prescribing. 
Individuals who had not participated in the program were included in a separate session to 
understand possible barriers to participation, the perceived utility of the program in meeting their 
medication needs, and overall knowledge about potentially inappropriate prescribing. Focus 
groups were chosen as the method for qualitative data collection to allow for the exchange of ideas 
and iterative response to questions through group discussions and dynamics. Additionally, focus 
group sessions were chosen instead of other qualitative research methods to identify the attitudes 
and reactions about the HomeMeds program through group interactions[53].  
Participants were selected through purposive sampling by a HomeMeds staff member 
(Jewish Community Center) and service coordinator (New Riverview Apartments). To recruit 
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individuals who had participated in the HomeMeds Program, a list of previous clients who may be 
interested in providing feedback through a focus group session was created by a HomeMeds staff 
member. Individuals from this list were contacted by telephone to explain the purpose of the focus 
group session and request participation. Two follow-up calls were placed to interested participants 
to confirm the focus group date and time and remind them of the upcoming session. Participants 
for the focus group session that was conducted with New Riverview residents were recruited by 
the New Riverview service coordinator. Individuals who had not participated in the HomeMeds 
program were specifically selected for this focus group session.  
Focus groups ran one-hour in length and were conducted in conference rooms located at 
each of the sites: the Jewish Community Center in Squirrel Hill and the New Riverview Towers 
Apartments located in Squirrel Hill South. The sessions were recorded using VoiceMemo software 
on a laptop computer. Verbal consent was provided by each of the focus group participants before 
beginning the session. Questions related to four pre-determined themes: knowledge about 
potentially inappropriate prescribing, issues related to medication management, barriers to 
HomeMeds, and facilitators to HomeMeds; were used to format the focus group session. Pre-
determined themes were developed from preliminary discussions with HomeMeds leadership 
about challenges with recruitment for the program and background literature on polypharmacy and 
adverse drug events. Questions related to these themes were formatted to evaluate the feasibility 
and acceptability of the program among the target population. Given the differing familiarity with 
the HomeMeds program between the groups, session guides were tailored to the type of respondent 
(see Table 2).   
Focus group sessions were recorded and descriptive notes were taken throughout. Focus 
group recordings were transcribed for data analysis. Responses were read through and commonly 
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repeated themes were noted. Unique perspectives that were reported during the sessions and 
relevant to the feasibility and acceptability of the HomeMeds program were also noted. These 
minority points of view were included in the data analyses to enhance the credibility of the 
qualitative findings[53]. Predetermined themes that were developed from discussions with 
HomeMeds leadership and existing literature were modified to incorporate new findings from 
participants. Additional codes were also developed to describe unexpected findings that emerged 
from the data. After review of the data, a codebook with a defined set of codes was developed and 
used for data analysis. Codes were tracked for frequency in each of the focus group session 
transcripts. Representative quotes were selected for succinctly describing key themes expressed 
during the session by a range of participants. 
Table 2. HomeMeds Focus Group Sessions: Question Examples 
Previous HomeMeds Participants Potential HomeMeds Participants 
What were your initial thoughts when you 
heard about the HomeMeds Program? 
Do you ever worry about medication 
problems? 
What made you decide to participate? Have you ever thought about how your 
medications might interact with one another? 
What did you find most useful about the 
HomeMeds Program? 
How would you deal with a problem with 
your medications? 
What were your initial thoughts after 
participating in HomeMeds? 
Have you ever heard about the HomeMeds 
Program? 
Is HomeMeds something you would 
participate in again? 
What are your initial thoughts about a 
program like this? 
When you think about the medications you 
take, are you ever worried about medication 
problems? 
Is HomeMeds something you would 
participate in? 
If you were inviting a friend to participate in 
HomeMeds, what would you tell them? 
Who would you trust to learn about a program 
like HomeMeds? 
If you were running the HomeMeds Program, 
what would you do differently? 
What do you think would make HomeMeds a 
better program? 
 
Other qualitative data for this project were collected using key informant interviews with 
HomeMeds personnel and a geriatric clinical pharmacist. Interviews were conducted over the 
phone or in-person using a semi-structured interview guide. Questions focused on the overall 
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intervention process, issues related to recruitment, and challenges experienced by HomeMeds 
staff. Two HomeMeds personnel were interviewed: a Giant Eagle pharmacist and a nurse navigator 
from the Jewish Association on Aging. Additionally, an interview with a geriatric clinical 
pharmacist from the UPMC Benedum Geriatric Center was conducted.  Interviews were requested 
with these individuals due to their key roles in the operation of the HomeMeds program or 
knowledge about medication management in older adults. Interviews were selected as a method of 
qualitative data collection to accommodate the schedules of key informants and to capture 
empirical data that were specific to their role and experience [53]. One interview was recorded 
using VoiceMemo on a laptop computer and transcribed verbatim. Verbal consent was provided 
by the participant before proceeding with the interview. Due to technical limitations, the remaining 
interviews were not audio recorded, but were documented using descriptive notes.  
Questions for key informant interviews related to five pre-determined themes: client 
population and needs, barriers to HomeMeds, facilitators to HomeMeds, the intervention process, 
and opportunities for improvement (see Table 3). These themes were developed based on 
background literature about pharmacist-led medication management programs for older adults and 
preliminary discussions with HomeMeds leadership about the program. Because the key 
informants were involved in different aspects of the HomeMeds program, additional questions that 
related to their specific role in the intervention process were included in each interview. The 
interview conducted with a geriatric clinical pharmacist at the Benedum Geriatric Center related 
to broader issues of medication management among older adults, barriers to navigating the health 
care system, and the perceived utility of the HomeMeds program in addressing the needs of the 
target population. The key informant interview transcript and descriptive notes were reviewed and 
commonly repeated themes were documented. Unique perspectives that were reported during the 
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interviews and relevant to the feasibility and acceptability of the program were also noted. To 
enhance the credibility of the qualitative findings, pre-determined themes were adapted to 
accurately describe the data[53]. Additional themes that were not pre-determined were developed 
based on findings that emerged from the interviews. These were included to provide more in-depth 
perspective about the program among the HomeMeds staff and experts in geriatric clinical 
pharmacy. A defined codebook was developed from this information and used to analyze the data 
by theme. Codes were tracked for frequency in the key informant interview transcript and 
descriptive interview notes. Representative quotes of themes expressed during the key informant 
interviews were selected and presented in the study findings. 
Table 3. HomeMeds Key Informant Interviews: Sample Questions 
3.2 Quantitative Data Collection and Analysis 
The HomeMeds software database is an essential tool for the operation of the HomeMeds 
program. The database serves as the platform to store client data and conduct medication risk 
assessments. As a result, quantitative data for this project were collected using the HomeMeds 
software database. Collected variables included participant demographics, frequency of 
medication alerts, client health history and intervention activities. Quantitative data from 1,045 
Sample Question Theme 
What types of health issues do your clients 
most often deal with? 
Client Population & Needs 
What issues do you most often experience in 
trying to implement the HomeMeds program? 
Barriers to HomeMeds 
What do you think make the HomeMeds 
program successful? 
Facilitators to HomeMeds 
What do you think would be most helpful to 
change about the HomeMeds program? 
Opportunities for Improvement 
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HomeMeds participants were analyzed for this project. Chi-square tests were conducted to 
determine whether participants with five or more prescriptions were more likely to have an alert 
generated in the database than those with fewer prescriptions. The data were used to determine the 
overall risks associated with polypharmacy among individuals who choose to participate. 
Additionally, bivariate descriptive statistics were performed to determine the relationship between 
generated medication alerts among participants and follow-up consultations with pharmacists. 
This information was used to determine whether the perceived risks of medications were 
significant enough to warrant further intervention by the Giant Eagle pharmacy team. All of this 
information was used to understand the overall benefit of the program to the participants. This 
study was a part of a quality improvement project for AgeWell Pittsburgh and was deemed exempt 
from IRB review. 
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4.0 Findings 
4.1 Qualitative Findings 
4.1.1 Focus Group Session: Jewish Community Center Members 
The focus group session conducted with previous HomeMeds participants was held in a 
bright conference room across from the AgeWell offices located at the Jewish Community Center 
in Squirrel Hill. The session took place on a Friday at 1pm. A total of five participants joined the 
session. Two individuals were unable to participate for the entirety of the session and, therefore, 
left early. Four of the participants were female and one participant was male. Three of the five 
participants were African American. Two participants were Caucasian. Three of the participants 
traveled to the session using the Access Transportation system, which provides transportation 
services to senior citizens and individuals with disabilities. All attendees reported regular use of 
the AgeWell services provided at the Jewish Community Center and had participated in the 
HomeMeds program at least one time before the focus group session. Coded variables and the 
frequency in which they were communicated during the focus group session at the Jewish 
Community Center are included in Table 4. Details on the themes for the focus group sessions are 
included in the Appendix. Qualitative Data Codebooks. 
Table 4. Focus Group Sessions: Themed Response Frequency 
Theme Jewish Community Center New Riverview Apartments 
Program Benefits 11 8 
Privacy 2 7 
Health Care Self-Efficacy 4 2 
Medication Management 
Challenges 
4 3 
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Negative Health Care 
Experience 
4 1 
Medication Knowledge & 
Beliefs 
8 5 
Trust in Health Care 
Providers 
5 10 
Utilization of Pharmacy 
Resources 
7 4 
Operational Improvements 3 2 
 
Representative quotes were selected to illustrate themes that were expressed during the 
session. Overall, participants reported that they experienced medication management 
challenges. Even with routines in place to organize and prepare their prescriptions, such as 
maintaining a list of all their medications or setting out their pills at the beginning of each week, 
they did not feel confident in their management skills. For example, one participant reported: 
“I make up every week, once a week, I put my meds together for one 
week. And yet, I have not been able to do it perfectly. I’m either missing one or 
one is somewhere else. I’m just wondering as I age, I’m gonna need somebody 
to help me do that.” 
Another focus group participant stated: 
“I do the same thing and then I forget to put maybe one pill in that slot 
that I’m supposed to take that day. And, so, and then there’s three you take in 
the evening.” 
Consequently, the perceived benefits of the program were the most frequently communicated 
theme during the session. For example, participants reported that the program served as an 
additional measure to ensure safe prescribing and medication routines. One woman stated: 
Table 4 Continued 
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“I thought this program might be a way to get a third-party who has no 
preconception about me to look at my medications and get back to me. And also, 
I would be more likely to share over-the-counter medications that I’m taking in, 
with the interview process that HomeMeds has.” 
An additional member reported:  
“You know, the more help, the more, the merrier, the different things you 
go to. . . You know, so I think a lot of the programs, you know, they can offer you 
things that can help you out at home, and make life easier, you know.” 
A commonly reported theme related to the participants’ knowledge and beliefs about 
medications. Their comments diverged into two different categories: current knowledge of 
medications and improved knowledge about medications that resulted directly from participation 
in the HomeMeds program. For responses that related to current knowledge about medications, 
participants communicated an understanding that medications affect individuals uniquely, can 
interact with one another negatively, and may respond differently if a person’s diet or physiological 
characteristics change. Improved knowledge about medications that resulted from participation in 
the program related to their understanding of possible medication prescribing errors that are made 
by providers and common in the health care system.  For example, one participant stated:  
“I question when I received new medication. Where before I would just 
accept it, you know, as a doctor, you know, knows what he’s doing or saying, 
whatever. But I question why they’re changing medication for that reason.” 
This also contributed to enhancing particpants’ health care self-efficacy, as explained by one 
individual:  
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“When they called me with the results, they really didn’t tell me anything 
I didn’t know on some level. But they put it together in a nice way that I hadn’t 
thought of. And that, um, encouraged me to talk to my doctor about, um, this is 
a potential problem. I don’t have it right now, but how do I tell if I’m getting it? 
. . .  And that’s something I’ll do in the future now with anything.” 
These findings lead to another frequently coded response: trust in health care providers. 
Many of the participants reported general mistrust in their prescribing doctors that resulted from 
communication issues and differences between the doctors’ opinion and the participants’ personal 
experience and knowledge about their health. For example, one attendee stated:  
“The doctors are doctors. They forget that we’re human beings with 
brains, I think. Some of the time they take a look at us and they say ‘Ugh, here’s 
your medicine. Take it. It has a few side effects.’ They don’t have the time to 
explain what I’m looking for.” 
Other participants stated their worries about whether health care providers were communicating 
with one another and if clinicians had a full understanding of the treatments they were receiving 
in all aspects of their health care. Another participant commented:  
“[the doctor] really doesn’t take that much time, and they don’t find out, 
really, what you’re taking or not taking. And, you can’t, even if you call them, 
you don’t even talk to your doctors. You go through other people, two and three 
people, and they call you in what? —24-hours, 48-hours or whatever.” 
Participants did comment on their utilization of pharmacy resources. One participant described 
that “people really have to be educated about the pharmacist, that they’re their friends.”  The 
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group agreed that a pharmacist was a key resource for navigating a complex health care system 
with multiple providers. They stressed that utilizing pharmacy resources for education about 
prescription drugs was a vital aspect of health care maintenance and promoted their health care 
self-efficacy. For example, a particpant explained:  
“And my pharmacist is a big help. He looks in the computer and looks 
for trial offers to see if I can get cheaper medications. So, your pharmacist can 
be helpful with your financial, too.” 
Additionally, they felt that as a result of the program, they are better equipped to question their 
doctors’ recommendations, initiate conversations with their pharmacists about their medications, 
and request information on the signs and symptoms of an adverse drug event.  
In general, the only barrier reported about participation in the HomeMeds program was the 
potential for a breach of confidentiality that one participant reported. She expressed her initial 
concerns with the privacy of her health care information when first approached about participating 
in the HomeMeds program. She stated:  
“My initial thought was, that’s asking for an awful lot of information. And, who’s getting 
this information? And, is it really worth it? Isn’t this something I can do myself by going to my 
pharmacist?” 
She added: 
“But, I’m giving the information to a third-party. And, although we were all told that it’s 
confidential, um, like you wonder who is getting the information. Is it just the pharmacist?” 
However, despite her apprehension, her relationship with the AgeWell Pittsburgh staff and 
knowledge from previous experiences with other programs convinced her to proceed with 
participation. Overall recommendations for the program from the Jewish Community Center focus 
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group related to operational improvements. For example, attendees suggested that increasing and 
enhancing the quality of advertisements could help with recruiting individuals for the program. 
Additionally, the group felt that providing monetary incentives for participants was important and 
may be a deciding factor in some individuals’ decision to take part in the program. Finally, one 
attendee thought it would be helpful to include specific education about the harms of potentially 
inappropriate prescribing during the HomeMeds visit. Furthermore, HomeMeds participants 
should be provided with tips on talking about their medications, so they have the skills necessary 
to communicate with health care providers in the future. He explained: 
“It would be nice if maybe they explained to them in a little bit more 
detail of what the program could do for them, as far as what having a positive 
relationship with their pharmacist. You know, what follow-up questions you 
need to ask, have it in writing, make sure that, um, you get the answer that you 
need. Things like that, instead of just coming in and telling you the pharmacist 
will give you call.” 
The attendee thought that this information would improve participants’ understanding of the 
program’s value. 
4.1.2 Focus Group Session: New Riverview Apartments Residents 
The focus group session that was conducted with residents of the New Riverview 
Apartment complex also took place on a Friday afternoon. The session was held in a small, beige 
activity room that was filled with tables, chairs, and bookshelves. The session began with two 
women, both Caucasian, who had been asked to join by the service coordinator at the apartment 
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complex. As the session progressed, two additional participants, both Caucasian females, joined. 
All participants resided in the New Riverview Apartment complex. Table 4 lists the frequency that 
each theme was communicated during the session. Representative quotes were chosen to describe 
reported themes. Despite the similarity in theme, the information provided by the New Riverview 
Apartments residents, who had not utilized the HomeMeds program services, presented very 
different perspectives than individuals who had participated in the program.  
Initially, participants expressed skepticism over the benefits of the HomeMeds program 
compared to their existing health care. One participant explained “What happens if a pharmacist 
disagrees with it and yet I’ve been taking it all these years? And why?” Similarly, another 
participant stated:  
I think there may be a possibility that I would call the doctor and say to 
him ‘should I participate?’ And see what that thought was. . . I’d want to know; 
do you actually benefit from what you learn from what they show you and what 
they figure out?” 
However, as the focus group progressed, the initial skepticism about the program decreased and 
participants stated that they didn’t see any harm with having an additional service check their 
medications. This occurred after receiving more details about the program goals and what 
participation in the program entailed. One particpant commented, “it sounds helpful and it sounds 
like you’re being protected in what you are taking.” 
The most commonly coded theme in the New Riverview transcript related to the 
participants’ health care self-efficacy. The participants were confident in their health care self-
efficacy and skills to appropriately manage their medications. Similar to the Jewish Community 
Center focus group session, participants described using regular practices to track their 
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medications, such as maintaining a list of their prescription drugs that they took to medical 
appointments. For example, one participant explained, “I have a list because when I go to the 
doctor, you know, to give to him to check.” They felt that the mechanisms they currently had in 
place were adequate for facilitating successful health care maintenance. When asked about 
potential challenges they faced with managing their medications, they explained that they did not 
experience any issues. According to one participant:  
“No, because I carry with me, not down here, but like when I go to the 
doctor, I have on a piece of paper my AM and PM medications. And after they 
examine me, and I ask them: ‘Do I need another medication?’ And if they say 
‘yes,’ I take that out.” 
Additionally, participants expressed the ability to communicate openly with their medical 
providers. They felt that if there was a perceived problem with their medications, they could speak 
to their doctor about it. One focus group member reported, “Listen if I couldn’t talk to them, what 
is the purpose of having them.” 
This leads to the second most commonly coded theme from the New Riverview session: 
trust in health care providers. Unlike the participants in the Jewish Community Center focus 
group, the New Riverview residents reported firm trust in their medical providers. For example, 
when asked if they ever had concerns about the medications that they take, one participant stated, 
“Mine are prescribed by the doctors and they know everything.” Additionally, participants 
reported that the health care system was conducive to accurate communication between their 
clinicians. According to one participant:  
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“I go to Pitt doctors, cause I have UPMC, and they can all just pull it up 
on the screen and see what I take. I mean my PCP doctor, my pulmonary doctor, 
my orthopedic doctor. They all know because they all belong to Pitt.” 
In addition to this, one participant felt that because they had so many clinicians involved in their 
health care, they should be over-protected from potential medication harms. She reported,  
“Because so many medical people have looked at my list and no one has 
ever said anything, ugh, I’m assuming they’re all working with each other.” 
There was a minority opionion expressed in the group that medical providers may not have a 
comprehensive understanding of an individual’s health care needs. The participant explained: 
“Well, it’s turned into now, I have many doctors. I don’t just have one. 
And I really question ‘do each of them look at what the other doctors given 
me?’” 
In relation to the theme of knowledge and beliefs about medication, participants reported 
knowledge that medications can have different effects on individuals. For example, a participant 
explained, “of course it doesn’t mean it’s gonna work for every person the same way.” One woman 
also expressed some concern over the ability for her body to handle the drugs that she takes. For 
example, she stated:  
“Many times, I question ‘How much are you going to give me.’ You know 
what I mean? How much different things can the body take? . . . I’m always 
afraid that it shouldn’t all of a sudden react opposite than what it’s supposed to 
do.” 
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Despite this, since negative reactions with her medications had not already occurred, she felt that 
these issues were not likely to be a problem. Additionally, the focus group members felt that 
utilization of pharmacy resources was a way to ensure medication safety. One participant 
commented, “A lot of people tell you pharmacists know more about medicine than doctors do.” 
As a result, they agreed that they would consider participating in the HomeMeds program.  
One negative aspect of the program that the participants discussed related to privacy and 
the potential for a breach of confidentiality with sensitive health care information. Participants 
expressed concern that their information would not be protected. One participant commented:  
“Well I wouldn’t want it discussed with someone else unless they told me 
who and why. It has to be confidential. But if they told me who it was and what 
was the purpose, I’d make up my mind of whether you should or shouldn’t 
discuss it.”  
Additionally, they explained that they would be reluctant to participate if the New Riverview 
Apartments staff did not clearly endorse and advertise the program. One woman stated:  
“Yeah. I mean if Misha [service coordinator] came out and said 
someone’s going to come up and give you a flyer, you know it’s a legitimate 
thing.”  
Because the program was operated through AgeWell Pittsburgh, an organization that was familiar 
to most participants, they reported that this would positively influence their decision to take part 
in the HomeMeds program. However, participants thought that they would be most likely to utilize 
HomeMeds services if they had a friend who had a positive experience with the program. Their 
recommendations for operational improvements were that a summary letter be sent to their home 
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before the pharmacist called them with the results of their review. Participants felt that they would 
not be able to understand the pharmacist’s findings without a document to help guide the 
discussion. One individual explained:  
“I would think it would work better if they sent out a letter with their 
findings and then the name and a phone number of somebody you could call if 
you had any questions about that information. I’m on enough meds, I don’t want 
anybody telling me over the phone because there’s too many of them.” 
Additionally, they felt that the communication between the HomeMeds pharmacist and their health 
care provider was essential for addressing possible issues with their medications. Though they had 
previously discussed their ability to openly communicate with their doctors, participants did not 
feel equipped to lead conversations that might challenge the recommendations provided by their 
primary care doctor. When discussing the importance of having the pharmacist communicate 
directly with their primary care doctor about the findings, one particpant explained: “They could 
fight the battle. I don’t know what to say to the doctor.” 
Overall, the New Riverview Apartments focus group participants felt that the program was 
a beneficial service for individuals with complex medications and health care issues. Their main 
concern was that information would not be kept confidential and the HomeMeds staff member 
may not be adequately trained or a licensed health care professional. Because the participants had 
trust in their health care providers and the health care system, they did not express a serious need 
for the HomeMeds program. However, if the previously mentioned concerns were addressed and 
adequately explained, they felt that there was no harm in utilizing the services provided by the 
program. As a result, all of the Riverview Apartments focus group members agreed that they would 
consider participating in the program. 
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4.1.3 Key Informant Interview: Jewish Association on Aging Nurse Navigator 
The interview with the nurse navigator from the Jewish Association on Aging was 
conducted over the telephone and lasted approximately 15 minutes. Due to technical limitations, 
the interview was not audio recorded. However, detailed notes were taken during the interview to 
record the nurse navigator’s responses. Given the nurse navigator’s role in the operation of the 
HomeMeds Program, the interview transcript was coded with different themes than those used to 
analyze the data from the focus group sessions. The Jewish Association on Aging provides senior 
and low-income living facilities, skilled nursing and rehabilitation facilities, home healthcare 
programs, and other health-related services to older adults in the greater Pittsburgh area. Details 
on the themes for the key informant interviews are included in the Appendix. Qualitative Data 
Codebooks. The most commonly coded theme (see Table 5) from this key informant interview 
related to the intervention process of the program as operated by the Jewish Association on 
Aging.  
Table 5. Key Informant Interviews: Themed Response Frequency 
Theme 
JAA Nurse 
Navigator 
Giant Eagle 
Pharmacist 
Geriatric 
Clinical 
Pharmacist 
Intervention Process 5 5 4 
Program Recruitment 3 1 0 
Tracking Data 0 3 3 
Client Attitudes 2 2 1 
Clinician Response 0 4 3 
Common Medication Issues 0 3 6 
Recommendations for Improvement 0 3 2 
Challenges 3 7 3 
 
The nurse navigator explained that when the program was provided to patients who 
received home healthcare, the client’s information is first reviewed by a nurse as a part of their 
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routine medical care. If the nurse was concerned about the medications the client was taking or if 
they had numerous prescriptions, the patient would be referred to the HomeMeds program. The 
nurse navigator would then enter the medications into the HomeMeds database for review by the 
Giant Eagle pharmacist. For individuals who did not receive home healthcare, but were living at 
the Jewish Association on Aging residential sites, the nurse interventionist would recruit them by 
directly approaching them about participation.  
Subsequently, the second most commonly reported theme during this key informant 
interview related to program recruitment. When attempting to recruit participants at Jewish 
Association on Aging sites, and not specifically through home healthcare programs, the nurse 
navigator explained: 
“It’s like speaking to a deaf audience, they have no clue who I am. They 
don’t know me at all.”  
As a result, she communicated that recruitment of individuals who do not receive home healthcare 
through the Jewish Association on Aging was the most common challenge she experienced. 
Consequently, the nurse navigator reported that her primary source of clients for the HomeMeds 
program was through the referral by home healthcare staff members. Otherwise, she reported that 
recruitment at the Jewish Association on Aging community residencies was essentially nonexistent 
and that individuals located at this site were not utilizing the services provided by the HomeMeds 
program. 
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4.1.4 Key Informant Interview: Giant Eagle Pharmacist 
The interview with the Giant Eagle clinical pharmacist was conducted over the telephone 
and lasted approximately 30 minutes. The interview was transcribed verbatim and coded with the 
same themes used for all of the key informant interviews. A team of eight pharmacists provide 
services for the HomeMeds program. However, the pharmacist interviewed for the purposes of 
this project was the main contact person for the HomeMeds program. Starting with the most 
common theme coded from the interview session (see Table 5), the pharmacist reported many 
challenges with implementing the program. The pharmacist cited that communication with 
HomeMeds staff, nursing facility staff, and clients were the main challenges that the Giant Eagle 
team experienced with the program. Oftentimes, efforts to relay information from the HomeMeds 
medication assessment were difficult because the client did not know the Giant Eagle pharmacist 
or remember participating in the program. Because older adults were especially prone to scams, 
this presented a challenge even when the pharmacists were persistent and clear in their follow-up 
communication about the program. For example, she stated:  
“A lot of, you know, the issue with it on our end, other than, like, the 
paperwork and stuff . . . is just like the skepticism around it is definitely a big 
issue – I think communication is definitely something we could improve upon.” 
Furthermore, if the client utilized home healthcare and the pharmacist tried to communicate with 
nursing facility staff, the pharmacy team experienced similar difficulties with communication. She 
explained:  
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“Sometimes times we do have a little bit more trouble talking to the 
nursing facility cause we have to leave messages and it’s, it’s a little bit more 
cumbersome to get a response.” 
Tracking data was one of the third most-frequently coded themes in the data analysis of 
the interview transcript. With regard to tracking data, the pharmacist reported that there were 
occasional errors in the information that was provided in the HomeMeds database. However, 
overall the information was accurate. She explained:  
“I think definitely, um, as far as like just kind of going through the 
medication list, sometimes there can be like, you know, errors made or typos, 
things like that. But, I think for the most part we get generally accurate 
information.” 
Additionally, the pharmacist described the comprehensive list maintained by the Giant Eagle 
pharmacy team that tracks information on every client with flagged medications in the HomeMeds 
database. Each month, the pharmacists reviewed this information and sent it back to the 
HomeMeds staff at AgeWell Pittsburgh. The pharmacist described the process for tracking this 
information:  
“I go through the spreadsheet and try and filter out, like, who we talked 
to, who we actually completed assessments with, um, and the assessments we 
addressed—we try to filter through how many therapy duplications do we have, 
how many NSAID indications.”  
This leads to the recommendations for improvements provided by the Giant Eagle 
pharmacist. Conducting this additional review of HomeMeds clients each month was reported as 
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time-intensive. As a result, the pharmacist recommended investigating whether this information 
could be provided directly from the HomeMeds database to reduce the time devoted to performing 
this task. She explained:  
“At this point, it’s such a manual process, we are hoping there is 
something that maybe we don’t know about and we are also trying to figure out 
what AgeWell really needs from us. We don’t know if we’re providing it because 
that’s how it’s always has been. Do they really need it? Cause if not, we’re doing 
a ton of work on the backend.” 
Additionally, enhancing awareness about the program could improve communication between the 
pharmacy and nursing staff. The pharmacist communicated that while some site staff were well-
educated about the program, others were often confused when the pharmacist placed follow-up 
calls about clients. Providing additional education about the program at these sites may facilitate 
better communication between Giant Eagle pharmacists and the home health staff members. 
 Common medication issues that the pharmacist cited during the interview were therapy 
duplications, nonsteroidal anti-inflammatory drugs (NSAIDs) prescribed for individuals over the 
age of 80, and possible harmful interactions between prescriptions and over-the-counter vitamins. 
They felt that these issues were most commonly found in clients who had complex health care 
needs that required multiple medications. This was most frequently seen in the clients who 
participated in the HomeMeds program operated through the Jewish Association on Aging. The 
pharmacist stated: 
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“I think, a lot of the times, specifically with the JAA patients that are in 
the home health program, a lot of the times it is like they’re on a lot of stuff cause 
they’re really sick and they have a lot of issues going on.” 
Consequently, they felt that the program was a useful resource for reviewing and identifying 
potential medication errors for the population of older adults with complex medication needs.  
Despite this, the pharmacist reported that because the program did not track outcomes, it 
was difficult to know whether a client’s health actually improved as a result of the intervention. 
Moreover, when the prescribing physician was contacted about a medication error or risk of an 
adverse drug event, the pharmacist reported that they rarely received a follow-up response. As the 
pharmacist explained, providers were typically contacted via fax machine with their findings from 
the medication risk assessment. It was uncommon for the pharmacist to call the physician directly 
about the program. As a result, overall, the Giant Eagle pharmacy team had very limited 
communication with the client’s regular health care provider. In the uncommon occurrence that 
there was a response, the physician was oftentimes already aware of the risks associated with the 
client’s prescription drugs. The pharmacist explained that some responses she had received were:  
“I think one or two faxes I’ve gotten back were kind of generally like 
‘This medication is needed. Not changing.’ Or something like that . . . They kind 
of say, you know, ‘We’re aware of the risk.’ But, um, like, benefit outweighs the 
risk in a lot of cases, so it is kind of, like, their clinical judgement call.” 
Subsequently, as explained by the responses related to the intervention process theme, a 
large part of the Giant Eagle pharmacy team’s role in the HomeMeds program was to understand 
why a client was taking a certain medication and if their findings were clinically relevant. As the 
pharmacist explained, alerts that were generated in the system did not always require a follow-up 
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call with the client or their physician. When a client’s medications were reviewed, the team 
assessed whether an alert warranted a follow-up consultation with the client. Sometimes, these 
alerts did not require additional intervention. However, if an alert was a concern to the team, they 
contacted the client with their findings and requested to contact their prescribing physician. The 
pharmacy team attempted to reach the client three times by telephone. If the pharmacist was unable 
to speak with the client, they would send a letter to their home and request that the client contact 
them to discuss the results. Due to HIPAA restrictions, no sensitive health information was 
included in these letters. Overall, the pharmacist reported that streamlining the communication 
between her team and the HomeMeds staff and clients would help to “ease up a chunk of time on 
our end.” 
4.1.5 Key Informant Interview: Benedum Geriatric Clinical Pharmacist 
The interview with the geriatric clinical pharmacist was conducted during an in-person 
meeting. Due to technical limitations, the interview was not audio recorded. However, detailed 
notes that recorded interview responses were documented. The information provided during the 
interview was coded with the same themes that were used for the other key informant interviews. 
The most common comments (see Table 5) from the geriatric clinical pharmacist related to 
challenges with medication management for older adults. The pharmacist explained that 
medication errors are most frequently associated with transitions of care.  She explained:  
“Major mistakes with discharging people from the hospital and clinical 
errors occur between the initial discharge and follow-up appointments. 
Oftentimes, what is listed on the print-out that is given to the discharged patient 
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is incorrect and they have no way of checking this until they see the doctor 
again.” 
Consequently, she commented that it was worthwhile for the program to identify common 
medication issues, such as therapeutic duplications, which frequently occur during transitions of 
care. However, based on comments related to the intervention process, the geriatric clinical 
pharmacist questioned the value of the program. Her main basis for this related to the lack of 
communication between the partnering Giant Eagle pharmacists and the participant’s primary care 
providers.  
The clinical pharmacist explained that, although the HomeMeds software would identify 
therapeutic duplications and potential risks with medication dosage, partnering Giant Eagle 
pharmacists would need additional clinical information about the patient to provide meaningful 
recommendations. She explained:  
“The software is not going to catch the things that matter. It will catch 
the easy things like duplications or extreme interactions. But knowing if drugs 
are appropriate for a person is much harder.” 
Additionally, if the participant had some sort of unknown cognitive impairment, providing 
recommendations to them without consultation with their primary physician may be problematic 
and could result in harm. Possible cognitive impairments and other errors may also impact the 
initial tracking of data during the assessment. For example, the pharmacist questioned the 
accuracy of the data entry by the HomeMeds staff. She explained, even with proper training, 
mistakes that occur frequently in the healthcare system may be just as common in the recording of 
patient information during the medication assessment. Moreover, she explained: 
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“I would worry about the accuracy of the intake and inventory of the 
medications. Are they checking how the patient currently takes the medications? 
Medications may change, but bottles don’t.” 
Because UPMC and Highmark insurance companies already utilize a form of HomeMeds 
Plus, which includes the medication assessment, review of the patient’s home environment, and 
linkage to additional services, the geriatric clinical pharmacist was unsure of whether the program 
was more valuable than the regular care available to these patients. The pharmacist did note the 
value of the program if it was able to target individuals from underserved backgrounds who might 
not have access to or utilize regular care.  
The recommendations for improvement provided by the geriatric clinical pharmacist 
were to have key staff, such as the service coordinator at the New Riverview Apartments, identify 
individuals who are most in need of the HomeMeds services. In addition, the pharmacist suggested 
partnering with a local medical provider who serves underrepresented patients and could 
recommend participants for the program.  
4.2 Quantitative Findings 
A total of 1,045 medical assessments conducted by the HomeMeds program were included 
in this study. The average HomeMeds client is an 82-year-old female who takes 10 medications. 
The most commonly diagnosed condition reported in the HomeMeds database is hypertension, 
which was found in 54.0% of the program clients. Additionally, 52.0% of HomeMeds participants 
reported a hospital or emergency department visit in the past three months (see Table 6).  
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Table 6. HomeMeds Participant Incidents & Symptoms 
Incident/Symptom Total Participants 
Fall 204 
Dizziness 150 
Confusion 65 
Hospital/ER Visit 541 
 
Of the total assessments, 1,028 had medications entered into the HomeMeds database. Almost 
60% of the medication assessments conducted through the HomeMeds program generated an alert 
within the database (see Table 7). The majority of alerts were for the use of NSAIDs in 80-year-
old individuals. However, it should be noted that out of the 604 assessments that generated alerts, 
only 207 of these alerts (34.3%) warranted a follow-up discussion between the client and the 
Table 7. HomeMeds Program Activities Summary 
HomeMeds Activities Total Participants 
Medication Assessments 1045 
Assessments with Medications Entered 1028 
Assessments with Alerts 604 
Assessments Reviewed by the Pharmacist 207 
Assessments with at Least One Resolution 207 
Assessments with Unresolved Alerts 65 
Assessments with Contact to the MD 16 
 
pharmacist. The explanation for this discrepancy was that all alerts did not require follow-up with 
the HomeMeds client. After the pharmacist reviewed the assessment, they may have found that 
the generated alert did not require intervention due to the information provided in the client’s 
profile (e.g. current medical conditions, health history, etc.). However, for the alerts that required 
intervention by the Giant Eagle pharmacist (i.e. follow-up communication with the client), all 
resulted in at least one resolution. Additionally, approximately 2.6% of assessments that generated 
an alert and were reviewed by the pharmacist resulted in additional contact with the prescribing 
doctor.  
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Chi-square analyses indicated that individuals who took five or more medications were 
significantly more likely to have an alert generated in the HomeMeds database during their 
assessment than those who took fewer than five medications (93.5% vs. 6.5%; χ2 = 69.1[3, n 
=1045]; p <0.001). Additionally, there was a significant difference (χ2 = 194.2 [3, n =1045]; p < 
0.001) between observed alerts that required intervention by the pharmacist and the alerts that did 
not require further involvement. As a result, alerts that were generated within the database were 
more likely to not require intervention after the pharmacist review than to require additional 
intervention (65.7% vs. 34.2%). There was also a significant difference (χ2 = 45.4 [3, n =1045]; p 
< 0.001) between the clients who reported falls and a hospital or emergency room visit in the past 
three months and those who had fallen, but reported no hospitalization (71.1% vs. 29.0%). 
Compared to individuals who did not report a fall in the past three months, those who did were 
significantly more likely to also report visiting a hospital or emergency room. 
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5.0 Discussion 
5.1 Summary of Results 
Overall, the findings from this study indicate clear differences in perspectives about the 
HomeMeds program between members of the target population who were former clients and those 
who had not used its services. These differences identify potential barriers to recruitment for the 
program. To start, it should be noted that the members of the focus group session with previous 
HomeMeds clients regularly used the services offered at the Jewish Community Center and had 
utilized other AgeWell Pittsburgh programs. They were also familiar with the AgeWell Pittsburgh 
staff, which may have influenced their participation in the focus group session. For example, when 
recruiting potential focus group members, mentioning the name of the AgeWell staff member who 
had referred them helped to endorse the study and likely supported their decision to participate. 
Likewise, this same familiarity with the organization and the AgeWell staff member who would 
be conducting the HomeMeds medication risk assessment may have had a significant impact on 
these individuals’ initial decision to participate in the program.   
The importance of trust and pre-existing relationships between HomeMeds staff and 
potential clients was evident in the findings from the session with the New Riverview apartments 
residents. This was first apparent in the coordination of the focus group session at this location, as 
recruitment for the session was conducted solely by the New Riverview Apartments service 
coordinator. Unlike the members of the session at the Jewish Community Center, these residents 
were not familiar with AgeWell staff members who conducted HomeMeds activities. Additionally, 
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as identified by the nurse navigator, lack of familiarity between HomeMeds staff and individuals 
at AgeWell residential sites contributed to significant challenges with recruitment for the program.  
This relates to an interesting theme that was not pre-determined and emerged during both 
focus group sessions: trust in health care providers. The previous HomeMeds clients indicated that 
the program served as a comprehensive review of their medications, which they would have 
otherwise not received in their routine medical care. Conversely, the majority of New Riverview 
focus group members indicated that, although it was not harmful to have an additional review of 
their medications, their current medical care was sufficient in keeping them safe. This difference 
in perspective is likely to stem, in part, from a lack of knowledge about the potential for errors in 
prescribing and inaccuracies in the electronic medical record. Consequently, without adequate 
understanding of the possible errors that exist in the electronic medical record, difficulties in care 
coordination between numerous health care providers, and risks for adverse drug events with 
multiple medications, the members of the target population may be reluctant to participate in a 
program for which they do not perceive a significant need. 
Additionally, previous participants felt that the program had improved their knowledge 
about medications and enhanced their health care self-efficacy. Participants cited that taking part 
in the HomeMeds program motivated them to engage in discussions with their health care 
providers and pharmacists about their medications. Therefore, in addition to the benefit of the 
medication risk assessment, participating in the program also heightened awareness about 
medication errors and served as a cue to action to take additional steps to maintain health. In 
comparison, the New Riverview residents initially reported skepticism about the utility of the 
program as they did not perceive challenges with their health care self-efficacy. However, a 
surprising finding was that as the session progressed, discussions about the goal of the program 
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(i.e. explaining potentially inappropriate prescribing and the need to prevent it) seemed to shift 
this perspective among the members. Additionally, the minority opinion expressed by one 
participant about the possible lack of communication between her clinicians helped to bring 
awareness of this issue to the group. Therefore, simply discussing the prevalence of potentially 
inappropriate prescribing in the health care system contributed to the focus group members’ 
understanding of the utility of the program in enhancing their health care self-efficacy.  
Data from the key informant interviews primarily related to the challenges experienced by 
staff and partnering pharmacists and noted by the geriatric clinical pharmacist. The main problems 
that were identified rose from difficulties with communication. These issues were reported at all 
levels, including between staff and potential clients for recruitment, clients and pharmacists about 
recommendations, and pharmacists and primary care providers with medication assessment 
results. Additionally, findings from key informant interviews related to the intervention process 
for each of the program personnel: staff and partnering pharmacists. The information provided in 
these interviews led to identification of possible opportunities to address issues with the 
intervention process and enhance the services provided to the HomeMeds clients.  
The main concerns with communication that were expressed by the partnering pharmacist 
were that given the lack of communication with primary care providers and reliance on clients to 
relay key information about their medications, partnering pharmacists faced challenges with 
providing clinically-relevant recommendations. Though the information collected about the client 
allowed for some understanding of their clinical history, lack of access to their medical record 
resulted in gaps in knowledge. As noted by the geriatric clinical pharmacist, additional issues with 
communicating results to clients were the possibility for a client’s cognitive impairment or 
difficulty interpreting the pharmacist’s recommendations. Without a direct line to the client’s 
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primary care provider, the program was not conducive to allowing partnering pharmacists to make 
an informed judgement about the client’s medications and ensure follow-through with their 
suggested changes.  
The quantitative findings of this study provide evidence that members of the target 
population who participate in the HomeMeds program are, indeed, at an increased risk for health 
complications that arise from medications. Almost 90% of HomeMeds clients took five or more 
medications, indicating that they experienced polypharmacy in their routine medical care. 
Moreover, quantitative findings evidenced that clients who took five or more medications were 
more likely to have an alert generated in the system than those who took less medications. 
Additionally, the clients who had experienced a fall, a common outcome of an adverse drug event, 
were also more likely to report an emergency room visit or hospitalization. Thus, the quantitative 
data in this study supports the evidence that polypharmacy is associated with an increased risk for 
adverse drug events, which are also associated with increased health care utilization. Additionally, 
given the high number of participants who were experiencing polypharmacy in their medical care, 
the quantitative findings indicate that the HomeMeds program was successful in reaching a 
majority of individuals who were technically at risk for an adverse drug event.  
Despite this, the majority of alerts that were generated in the system did not require follow-
up communication between the pharmacist and the client. This suggests that, upon review, the 
alerts were determined to be clinically insignificant and did not necessitate remediation by the 
partnering pharmacist. These quantitative findings further support the qualitative data reported by 
the partnering and geriatric clinical pharmacist that the risks identified within the database were 
likely to be outweighed by the benefit of the medication for the client. However, it should be noted 
that given the partnering pharmacist’s gaps in knowledge about the client’s treatment, these 
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determinations were made without a full understanding of the client’s medical history. As noted 
by the geriatric clinical pharmacist, aside from addressing therapeutic duplications that were easily 
identified by the HomeMeds software, the medication review and subsequent determinations about 
the safety of the client’s prescription and non-prescription drugs was limited. Furthermore, because 
follow-up information was not recorded, it was impossible to measure whether the pharmacist’s 
recommendations or lack thereof actually prevented or delayed additional hospitalizations.  
Among the alerts that did require communication from the pharmacist and the client about 
their medications, the majority of these discussions did not result in additional contact with the 
primary care provider. It is possible that this is because medication issues were resolved without 
intervention from the primary care provider. However, it is also possible that clients did not 
consent to contacting their primary care provider, even if the partnering pharmacist recommended 
further communication. One possible explanation for this is the concern reported during the New 
Riverview focus group that recommendations provided by an outside pharmacist may question 
their primary care provider’s expertise, which could negatively impact the client’s relationship 
with their doctor. Accordingly, this same concern may have also contributed to client’s reluctance 
to communicate results from the medication risk assessment to their primary care provider. 
There are several limitations to this study. One of the main limitations was that only two 
focus groups were conducted for qualitative data collection. Due to time constraints and difficulty 
with recruiting participants, it was not possible to conduct multiple focus group sessions with 
members of the HomeMeds target population. Therefore, thematic saturation was not achieved. 
Furthermore, despite efforts to conduct focus group sessions with past participants who had diverse 
experiences with the HomeMeds program, it is likely that those who chose to participate had a 
positive experience with the program and the other AgeWell Pittsburgh services. Thus, feedback 
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provided by previous HomeMeds clients may have been biased. Subsequently, there was limited 
generalizability of the findings discovered during the focus group sessions outside of the two 
groups of the target population that were examined. Finally, only one key informant interview was 
audio recorded. The other two interviews were documented using descriptive notes. As a result, it 
is likely that data from these two key informants were lost during the interview process. 
In addition to limitations to the qualitative data, the quantitative data had limitations. For 
instance, it was not possible to identify the client profiles with assessments that resulted in follow 
up communication with their primary health care provider. Therefore, review of these clients’ 
medication assessments was not possible. Consequently, possible factors that may have 
contributed to communication with the primary care provider were not identified. Without this 
information, strategies to increase the communication with medical providers, which may have 
otherwise enhanced the recommendations for the program, were limited. Finally, the quantitative 
data provided in the HomeMeds database was a result of information collected from clients across 
the AgeWell Pittsburgh sites. However, the qualitative data in this study was limited to affiliates 
of AgeWell Pittsburgh at the Jewish Community Center and residents at the New Riverview 
Apartments. As a result, to strengthen the findings of this study, the quantitative data analysis 
should have been limited to these two sites within the AgeWell Pittsburgh organization. However, 
it was not possible to filter the data by AgeWell Pittsburgh site. 
One strength of this study is that it is the first known formal mixed methods evaluation of 
the HomeMeds Program at AgeWell Pittsburgh. The use of mixed methods provided qualitative 
data that enriched and clarified the quantitative findings from the HomeMeds database. 
Additionally, through the use of focus group sessions with members of the target population and 
key informant interviews with various HomeMeds staff and experts in geriatric pharmacy, the 
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qualitative data includes a variety of valuable perspectives to help inform next steps of the 
program. Other strengths are found in the comprehensive set of information available in the 
HomeMeds database that provided the quantitative data for this study. Though accessing clients’ 
health history was identified as a challenge for pharmacists, the information in the HomeMeds 
database provides a valuable snapshot of the demographics, diagnoses, and medications of over 
1,000 older adults in Pittsburgh. Consequently, the HomeMeds database was a useful tool for 
understanding the health care issues commonly experienced by this population.  
5.2 Recommendations for Improvement 
Given the findings of this study, possible future directions for this program should focus 
on improving recruitment with individuals at the AgeWell Pittsburgh residential sites who do not 
receive home healthcare. This begins by improving knowledge about medications and risks 
associated with potentially inappropriate prescribing among these individuals. The members of the 
target population who had not utilized the HomeMeds services initially expressed skepticism about 
the overall benefit of participating in the program and confidence in the infallibility of the 
healthcare system and electronic medical record. As exemplified by the Health Belief Model, an 
individual is more likely to partake in a health-related behavior if they have a desire to identify or 
avoid a particular health outcome and if they believe that a certain action will prevent this outcome. 
In order to achieve this health-related behavior, the individual must first understand their 
susceptibility for a specific health outcome. This is also demonstrated by the shift in the New 
Riverview residents’ perspectives about the program after understanding the prevalence of 
inappropriate prescribing in the health care system. Thus, the first step in improving recruitment 
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among this sect of the target population is to provide education to raise awareness about the 
prevalence of adverse drug events among older adults, potentially inappropriate prescribing by 
health care providers, and therapeutic duplications that often occur during transitions of care. 
According to the Health Belief Model, individuals must also understand the severity of 
experiencing a particular health outcome to partake in a specific health-behavior. Subsequently, 
education for the target population should include information about the consequences (e.g. 
hospitalization, reduced cognitive ability, failure to complete activities of daily living, and death) 
that may result from these risks. While these consequences may induce fear, the Health Belief 
Model conceives that, with the availability of a specific health-behavior that might prevent this 
outcome, individuals will have an increased desire to perform this particular action. However, the 
Health Belief Model also theorizes that the benefits to engaging in this behavior must outweigh 
the barriers to participation. As noted by the New Riverview residents, a significant barrier to their 
participation in the program was lack of trust in the staff member conducting the HomeMeds 
activities and fear of breach of confidentiality. Consequently, members of the target population 
must be confident that the individual performing their medication risk assessment is a legitimate, 
trained staff member and that information is not documented outside of the secure HomeMeds 
database.  
While it is clear that current recruitment efforts include various aspects of the Health Belief 
Model, possible ways to improve the program should shift how information is relayed to potential 
clients. A key asset to the HomeMeds program is its partnership with community pharmacists, 
who are specially-trained to communicate medication information to non-clinicians. As a result, 
the HomeMeds program should leverage the partnering Giant Eagle pharmacy team to educate 
members of the target population about polypharmacy, adverse drug events, and potentially 
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inappropriate prescribing. One way to do this is to host an educational session led by partnering 
pharmacists at AgeWell Pittsburgh sites. This forum could be used to provide the information 
necessary for individuals to increase their understanding of the susceptibility and severity of these 
medication risks. Additionally, because community pharmacists are well-regarded medical 
providers who often interface with patients, their promotion of HomeMeds may help to overcome 
skepticism about the program and elicit participation. Even if attendees do not participate in the 
program, the information provided during the educational session may improve their health care 
self-efficacy and enhance their ability to engage in future communication with clinicians about 
their prescription and non-prescription drugs. 
Another possible change in the operations of HomeMeds would be to utilize program 
champions to encourage participation. Sites that have the most success with recruiting individuals 
to the program often benefit from a HomeMeds staff member who interacts frequently with 
affiliated members of the target population. For locations that do not have a HomeMeds staff 
person regularly present, partnering with other staff members at the site may help to promote the 
program. Additionally, these staff members may have specific knowledge about individuals to 
help identify those most in need of the HomeMeds services. Without this knowledge, it is likely 
that individuals from these sites who choose to participate already have an increased awareness 
about their perceived risk and susceptibility for medication issues. Therefore, they may already 
engage in conversations about their prescription and non-prescription drugs with their medical 
providers.  
In addition, given their willingness to partake in this program, it is possible that these 
individuals are already linked to other services that help them to maintain their independence. 
Thus, it is possible that recruitment efforts at these sites fail to connect with vulnerable older adults 
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in need of a medication risk assessment. The inclusion of a program champion at sites that 
experience difficulties with recruitment would also serve as a valuable endorsement of 
HomeMeds. This is especially important for engaging with individuals who are wary of involving 
additional services in their medical care. As a result, the involvement of a program champion may 
enhance engagement with vulnerable individuals and diminish the perceived barriers that interfere 
with their decision to participate in HomeMeds. 
Finally, as reported by the partnering Giant Eagle pharmacist and the geriatric clinical 
pharmacist, a significant challenge to the operations of the program is the lack of comprehensive 
information about the client’s health when making clinical decisions. Without this crucial 
information, the work required to make a sound clinical judgement and provide recommendations 
may be futile. Subsequently, possible future considerations for the HomeMeds program should 
include a partnership with a local primary care practice. Similar to the involvement of a program 
champion, a partnership with a local medical provider could improve the program’s outreach to 
the older adults who have the greatest need for assistance with medication management. For 
example, the health care provider could also recommend the HomeMeds services to clients who 
have recently experienced a transition of care or have complex medication regimens. Additionally, 
through this partnership, the Giant Eagle pharmacy team could have access to the critical 
information that is necessary when making clinically-meaningful recommendations about a 
client’s prescription and non-prescription drugs.  
It should be noted that evidence from a systematic review of other medication management 
programs for older adults did not find a significant decrease in the hospitalizations, emergency 
department visits, mortality, quality of life, mental health or physical function among program 
participants[54]. Thus, in order to truly understand the value of the AgeWell Pittsburgh 
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HomeMeds Medication Assurance Program, opportunities to evaluate client outcomes must be a 
priority. Through a partnership with a local primary care practice, the program could track the 
outcomes of clients to measure whether participation in the program has a positive impact on their 
health. Evaluations could examine client’s health care utilization, changes to prescription drugs, 
and mortality 6- and 12-months after their medication risk assessment. As a result, this information 
would provide a better understanding of the overall utility of the program in preventing or delaying 
adverse health outcomes that are caused by medications among participants.  
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6.0 Conclusion 
Overall, the HomeMeds Medication Assurance Program that is operated by AgeWell 
Pittsburgh is a noteworthy service to keep older adults safely at home through the identification of 
medication errors and the prevention of adverse drug events. This program attempts to obviate the 
individual-level consequences and health system-wide challenges that stem from these medication 
issues. However, considering the program challenges with recruiting vulnerable older adults, 
limited information provided to partnering pharmacists, and the intervention activities that occur 
after medication risk assessments, other avenues for driving this mission should be explored. 
Future considerations for HomeMeds should focus on addressing each of these key challenges to 
improve the implementation of the program and enhance its services. 
While it is clear that the majority of AgeWell clients experience polypharmacy and are 
susceptible to the associated risks, recruitment for the program will be stagnant if members of the 
target population have limited knowledge about this issue. One of the main benefits of the program 
that was cited by previous participants was improved knowledge about medication errors and 
health care self-efficacy. Thus, employing a community pharmacist to educate the target 
population about medication risks may help older adults at AgeWell sites understand the 
importance of this problem. Focusing recruitment efforts on first providing education to the target 
population may motivate older adults to utilize the HomeMeds program and encourage 
communication with their primary care providers about medications. These efforts could help to 
improve participation at sites that experience the most challenges with recruitment while also 
enhancing individuals’ self-efficacy when engaging with medical providers. 
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Furthermore, though HomeMeds is a useful program to promote proper medication 
management, older adults may be reluctant to involve a service that requires providing sensitive 
health care information to individuals with whom they do not have a pre-existing relationship. This 
may be especially true for older adults who experience issues with linkage to and engagement with 
care—individuals who have the most need for a program like HomeMeds. However, designating 
an AgeWell staff member as a program champion could help to identify and elicit participation 
from vulnerable individuals in this population. This would ensure that the HomeMeds program 
reaches the older adults who are otherwise unlikely to use additional health care services or consult 
regularly with their medical providers. By leveraging a program champion at AgeWell residential 
sites, HomeMeds would have more success with outreach to the vulnerable older adults who would 
benefit the most from a medication risk assessment.  
Other considerations for HomeMeds should include improving program operations so the 
Giant Eagle pharmacy team has access to the information necessary for providing meaningful 
recommendations for medication risk assessments. The majority of alerts that were generated in 
the HomeMeds database were determined to be clinically insignificant. Thus, efforts to implement 
the program may be futile if the benefits of certain medications ultimately outweigh the associated 
risks for the majority of HomeMeds clients. Partnering with a local primary care practice in 
Pittsburgh would help ensure that pharmacists’ recommendations are accurate and the operation 
of the program is worthwhile. Finally, a partnership with a local primary care practice could 
facilitate evaluation of the program. Aside from identifying therapeutic duplications or problems 
with non-prescription medications, it is likely that HomeMeds is limited in its ability to 
significantly address potentially inappropriate prescribing in older adults. To truly understand the 
utility of the program, follow-up evaluations of clients are needed. This information is crucial to 
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understanding whether the program is consistent with emerging literature that similar interventions 
do not cause a significant change in clients’ health outcomes. Future directions for the HomeMeds 
program should involve evaluation of client health outcomes to measure the program’s ability to 
keep older adults living safely and independently in their homes. 
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Appendix. Qualitative Data Codebooks  
Appendix Table 1. Focus Group Session Codebook 
Code Definition Included Concepts 
Benefits of program 
Perceived or real 
positive outcomes that 
resulted from 
participation in the 
program 
- Prevention of adverse drug 
events 
- Identification of medication 
errors 
- Assistance with medication 
management 
- Safeguards medications 
Privacy  
Data security and 
confidentiality  
- Disclosure of sensitive 
information  
- Professionalism of staff  
- Legitimacy of program 
Health care self-
efficacy 
An individual's ability to 
execute the actions 
necessary to achieve a 
state of physical, mental 
and social well-being in 
which disease and 
infirmity are absent 
- Medication management 
practices 
- Ability to communicate with 
clinicians 
- Confidence in independent 
health maintenance 
Challenges with 
managing medications 
Problems associated 
with medication 
adherence 
- Confusion about medications  
- Complex medication routines 
- Mistakes made when taking 
medications 
Knowledge and beliefs 
about medication 
Understanding of basic 
medication information 
and knowledge about 
medication errors; 
health-literacy 
- Awareness of adverse drug 
events, prescribing errors 
- Effect of individual physiologic 
factors on drug reaction 
Trust in health care 
provider 
Belief in the reliability 
and proficiency of 
medical providers to 
execute the actions 
necessary to promote an 
individual's health 
- Provider’s understanding of 
client’s medical needs 
- Communication with healthcare 
provider 
- Accuracy of the electronic 
medical record 
Utilization of 
pharmacy resources 
Use of pharmaceutical 
services; pharmacist’s 
role in medication 
management and 
education 
- Pharmacist is friend 
- Pharmacist knows more about 
medications than doctors 
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Operational 
improvements 
Functional changes to 
increase the capacity of 
the HomeMeds program 
to perform medication 
risk assessments and 
address medication 
needs for older adults 
- More advertising 
- Program incentives 
- Better communication 
  
Appendix Table 1 Continued 
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Appendix Table 2. Key Informant Interview Codebook 
Code Definition Included Concepts 
Intervention Process Actions executed to operate 
the HomeMeds program and 
conduct medication risk 
assessments for older adults 
- Database entry process 
- Home health care 
mechanism for referral 
- Medication risk assessment 
review process 
- Communication 
strategies/routine 
Program 
Recruitment 
Process of adding new 
participants to the HomeMeds 
program  
- Target population 
willingness to participant in 
program  
- Individual awareness about 
the program  
Tracking Data Measuring recorded 
information  
- Client information  
- Accuracy of information in 
database 
- Review of client information 
Client Attitudes How clients viewed the 
program or personnel when 
carrying out program 
operations 
- Suspicion 
- Lack of recognition 
- Grateful 
Clinician Response How physicians viewed the 
program or personnel when 
carrying out program 
operations 
- Suspicion 
- Lack of recognition 
- Grateful 
Recommendations 
for Improvement 
Functional changes to increase 
the capacity of the HomeMeds 
program to perform medication 
risk assessments for older 
adults 
- Streamlining communication  
- Increasing program 
awareness  
- Access to health information 
for medication assessments 
Challenges Difficulties in achieving 
program goals 
- Barriers to communication 
- Lack of engagement with 
target population  
- Gaps in knowledge about 
client’s health 
- Time 
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